DDrare: Database of Drug Development for Rare Diseases

Mangafodipir (DrugBank: Mangafodipir)

2 diseases

ID	Disease name (Link within this page)	Number of trials
13	Multiple sclerosis/Neuromyelitis optica	1
58	Hypertrophic cardiomyopathy	1

13. Multiple sclerosis/Neuromyelitis optica [ 3,050 clinical trials, 2,147 drugs, (DrugBank: 348 drugs), 244 drug target genes, 228 drug target pathways]

Searched query = "Multiple sclerosis/Neuromyelitis optica", "Multiple sclerosis", "Neuromyelitis optica", "MS", "NMOSD", "Devic disease", "Balo concentric sclerosis", "Baló concentric sclerosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 3,050 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01326715 (ClinicalTrials.gov)	October 17, 2013	30/3/2011	Manganese-Enhanced Magnetic Resonance Imaging in Healthy Volunteers and People With Multiple Sclerosis	Manganese-Enhanced Magnetic Resonance Imaging in Healthy Volunteers and People With Multiple Sclerosis	Multiple Sclerosis	Drug: Mangafodipir (Teslascan)	National Institute of Neurological Disorders and Stroke (NINDS)	NULL	Completed	18 Years	70 Years	All	17	Phase 1	United States

58. Hypertrophic cardiomyopathy [ 92 clinical trials, 126 drugs, (DrugBank: 35 drugs), 40 drug target genes, 141 drug target pathways]

Searched query = "Hypertrophic cardiomyopathy"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 92 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03607669 (ClinicalTrials.gov)	June 1, 2018	20/7/2018	Manganese-Enhanced Magnetic Resonance Imaging of the Myocardium	Manganese-Enhanced Magnetic Resonance Imaging: Applications in Cardiomyopathy	Ischemic Cardiomyopathy;Dilated Cardiomyopathy;Hypertrophic Cardiomyopathy	Other: Mangafodipir trisodium	University of Edinburgh	NULL	Unknown status	18 Years	65 Years	All	90		United Kingdom